UNC School of Medicine announces new kind of test for COVID-19
Category: #health  By Mateen Dalal  Date: 2020-06-13
  • share
  • Twitter
  • Facebook
  • LinkedIn

UNC School of Medicine announces new kind of test for COVID-19

With the number of people testing positive for COVID-19 increasing to over 7.5 million, the need for extensively applicable surveillance testing for better understanding of infection rates, particularly the number of infections in people with no or mild symptoms, is of paramount importance.

In a bid to simplify COVID-19 testing across the globe, researchers at UNC School of Medicine have reportedly developed a new kind of antibody test that would help labs that don’t have resources of commercial labs and academic centers to test thousands of blood samples.

Sources cite that the researchers created a blood test to identify SARS-CoV-2 antibodies that target RBD (Receptor Binding Domain) of the SARS-CoV-2 spike protein. The RBD-based antibody test measures the levels of that domain which associate to the levels of the important neutralizing antibodies that strengthen immunity.

The RBD of the spike protein in coronavirus is not shared among other known animal and human coronaviruses. Thus, antibodies against this domain are highly specific to SARS-CoV-2. These antibodies are present in the individuals who have been exposed to the coronavirus related to COVID-19.

Certainly, when scientists tested blood collected from individuals exposed to other types of coronaviruses, no one had antibodies to the RBD of SARS-CoV-2.

Commenting on this new study, co-senior author Aravinda de Silva said that the study is very specific for antibodies to the SARS-COV-2, which is not the case for some existing available antibody tests.

Mr. De Silva added that the study’s outcomes strongly support the use of RBD-based antibody evaluates for population-level observation and as a correlate of the neutralizing antibody levels in individuals who have recovered from COVID-19.

For the development of this new testing methods, researchers studied large number of SARC-Cov-2 infected patients.

Source Credit - https://www.news-medical.net/news/20200611/UNC-scientists-develop-new-kind-of-antibody-test-for-COVID-19.aspx

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

AI-centric study abroad platform Edvoy launched by IEC Abroad in India
AI-centric study abroad platform Edvoy launched by IEC Abroad in India
By Mateen Dalal

AI oriented study abroad platform, Edvoy, based out of UK, has reportedly declared its launch in India.  Edvoy, created by IEC Abroad, is a free digital platform that provides impartial advice, support, and content to prospective international s...

Centuria announces Augusta Capital takeover offer to be unconditional
Centuria announces Augusta Capital takeover offer to be unconditional
By Mateen Dalal

  Acceptance to takeover represent 65.86% of Augusta’s shares Takeover provide shareholders with NZ$0.22 in cash and 0.392 Centuria stapled securities for every share of Augusta Centuria’s assets under management will increase b...

High likeliness of COVID-19 damaging the brain, claim scientists
High likeliness of COVID-19 damaging the brain, claim scientists
By Mateen Dalal

The advent of COVID-19 has turned out to be one of worst disasters the world has seen in recent times. In an attempt to thwart its spread, myriad efforts are being undertaken, along the likes of social distancing, nationwide lockdowns, vaccine resear...